{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:58:15Z","timestamp":1774789095207,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR-Joo8605\/1"],"award-info":[{"award-number":["MR-Joo8605\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1001757"],"award-info":[{"award-number":["G1001757"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N023668\/1"],"award-info":[{"award-number":["MR\/N023668\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197299","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T13:27:55Z","timestamp":1526563675000},"page":"e0197299","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1"],"prefix":"10.1371","volume":"13","author":[{"given":"Nicola J.","family":"Borthwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirusha","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathifa","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Baines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund G.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian D.","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-9546","authenticated-orcid":true,"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Pepys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0006-291X(87)91111-9","article-title":"Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum","volume":"148","author":"MB Pepys","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2567.2004.01860.x","article-title":"Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?","volume":"112","author":"JD Gillmore","year":"2004","journal-title":"Immunology"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.4049\/jimmunol.1003641","article-title":"Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines","volume":"186","author":"Y Wang","year":"2011","journal-title":"Journal of immunology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gt.2011.67","article-title":"Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: implications for human DNA vaccine","volume":"19","author":"Y Wang","year":"2012","journal-title":"Gene Ther"},{"issue":"6886","key":"ref5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"MB Pepys","year":"2002","journal-title":"Nature"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14712598.2014.885946","article-title":"Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines","volume":"14","author":"T Hanke","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"S Letourneau","year":"2007","journal-title":"PloS one"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"N Borthwick","year":"2014","journal-title":"Mol Ther"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.20.1.21171","article-title":"Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects","volume":"20","author":"G Hancock","year":"2017","journal-title":"Journal of the International AIDS Society"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"e101591","DOI":"10.1371\/journal.pone.0101591","article-title":"Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial","volume":"9","author":"EJ Hayton","year":"2014","journal-title":"PloS one"},{"key":"ref11","unstructured":"Mothe B, Manzardo C, Snachez-Bernabeau A, Coll P, Moron S, Peurtas MC, et al. Therapeutic ChAdV63.HIVconsv-MVA.HIVconsv vaccination refocused T cells to conserved regions of HIV in early reated HIV-1 infected individuals (BCN 01 study). Submitted."},{"key":"ref12","unstructured":"Mothe B, Molt\u00f3 J, Manzardo C, Coll J, Puertas MC, Martinez-Picado J, et al. Viral control induced by HIVconsv vaccines & Romidepsin in early treated individuals. The Conference on Retroviruses and Opportunistic Infections; Seattle, WA, USA2017."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1016\/j.vaccine.2013.06.068","article-title":"Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB\/c mice","volume":"31","author":"B Ondondo","year":"2013","journal-title":"Vaccine"},{"issue":"9653","key":"ref14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"e0181382","DOI":"10.1371\/journal.pone.0181382","article-title":"Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA\/simian adenovirus\/MVA vaccine regimens","volume":"12","author":"N Moyo","year":"2017","journal-title":"PloS one"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"N Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.vaccine.2015.12.021","article-title":"Control of HIV-1 replication in vitro by vaccine-induced human CD8 T cells through conserved subdominant Pol epitopes","volume":"34","author":"T Ahmed","year":"2016","journal-title":"Vaccine"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2012.05.011","article-title":"Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells","volume":"382","author":"OD Defawe","year":"2012","journal-title":"Journal of immunological methods"},{"issue":"2\u20133","key":"ref19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-8981(91)90090-Y","article-title":"Serum amyloid P component in chronic renal failure and dialysis","volume":"200","author":"SR Nelson","year":"1991","journal-title":"Clin Chim Acta"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.82493-0","article-title":"Clinical experience with plasmid DNA- and modified vaccinia vaccine Ankara (MVA)-vectored HIV-1 clade A vaccine inducing T cells","volume":"88","author":"T Hanke","year":"2007","journal-title":"J Gen Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/mtm.2016.61","article-title":"Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults","volume":"3","author":"G Mutua","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e0176418","DOI":"10.1371\/journal.pone.0176418","article-title":"Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines","volume":"12","author":"N Borthwick","year":"2017","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:12:26Z","timestamp":1540343546000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197299"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197299","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]}}}